CS Health

CSL is a leading global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines. The company operates through three primary businesses: CSL Behring, which focuses on plasma-derived and recombinant therapeutic proteins for rare and serious diseases; CSL Seqirus, one of the world's largest influenza vaccine providers; and CSL Vifor, a leader in iron deficiency and nephrology. CSL maintains a robust R&D pipeline focusing on immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. With a significant global footprint, the company is a major provider of life-saving medicines for patients with hemophilia, immune deficiencies, and other critical conditions.